appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is overpriced and in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Nucleus Software Exports Ltd leads losers in ‘B’ group
4 months ago•Business Standard
NGL Fine Chem soars 13% on strong operational performance in Q4
1 year ago•Moneycontrol
Biofil Chemicals & Pharmaceuticals Ltd leads gainers in ‘B’ group
2 years ago•Business Standard
NGL Fine Chem consolidated net profit declines 66.43% in the September 2022 quarter
2 years ago•Business Standard
NGL Fine Chem standalone net profit declines 65.05% in the September 2022 quarter
2 years ago•Business Standard
NGL Fine Chem standalone net profit declines 45.07% in the March 2022 quarter
2 years ago•Business Standard
NGL Fine Chem consolidated net profit declines 50.36% in the March 2022 quarter
2 years ago•Business Standard